Evolving with Purpose: Janssen’s New Identity within Johnson & Johnson

Evolving with Purpose: Janssen’s New Identity within Johnson & JohnsonПодробнее

Janssen single dose vaccineПодробнее

Shaping Healthcare's Future: Johnson & Johnson's Vision for Innovative MedicineПодробнее

Johnson & Johnson announces split into two companiesПодробнее

FDA approves clinical trial application for Johnson & Johnson’s COVID-19 vaccine | ANCПодробнее

2022 Edelman Finalist - Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen)Подробнее

Johnson & Johnson Proposes $9 Billion Settlement Over Talcum Baby Powder LawsuitsПодробнее

Dual Transformation in Practice at Janssen Pharmaceutical Companies of Johnson & JohnsonПодробнее

We are Johnson & Johnson Innovative MedicineПодробнее

This House Hold Company Is Way Bigger Than You Thought: Johnson and JohnsonПодробнее

Johnson & Johnson Engineer: Nikunj, Janssen R&D USПодробнее

S. Korea reviews Johnson & Johnson's COVID-19 vaccine for approvalПодробнее

Oklahoma Accuses Johnson & Johnson of Fueling U.s. Opioid Epidemic in First-of-Its-Kind TrialПодробнее

Dr. Paul Janssen Award History | Johnson and JohnsonПодробнее

Why J&J's History and Credo Influences Decisions Today | Johnson and Johnson CEO | Alex GorskyПодробнее

Johnson & Johnson (Janssen) Vaccine arrives at Tufts MCПодробнее

Champions of Science: Dr. Paul Janssen Award webcast LIVE on September 16 at 1 p.m. ETПодробнее

Janssen (Johnson & Johnson) | Domenico Annese | PHARMAP 2022Подробнее

WiSTEM²D at J&JПодробнее

2021 Dr. Paul Janssen Award Call for Nominations | Johnson & JohnsonПодробнее